Long-Term, Open-Label Safety and Efficacy of Atomoxetine in Adults With ADHD
Authors:
- 30 April 2008
- journal article
- research article
- Published by SAGE Publications in Journal of Attention Disorders
- Vol. 12 (3) , 248-253
Abstract
Objective: Previously, data from 97 weeks of open-label atomoxetine treatment of adults with attention-deficit/hyperactivity disorder (ADHD) were reported. This final report of that study presents results from over 4 years of treatment. Method: Results were derived from the study of 384 patients (125 patients remaining in the open-label trial since the interim report), receiving up to 221 weeks of treatment. Primary efficacy measure was the Conners' Adult ADHD Rating Scale—Investigator Rated: Screening Version (CAARS-Inv:SV) Total ADHD Symptom score. Adverse events and vital signs were assessed. Results: CAARS-Inv:SV Total ADHD Symptom scores decreased 30.2% (p < .001) during treatment. Similar, significant decreases were noted for the secondary efficacy measures, including the Sheehan Disability Scale Total score, which improved 25.3% (p < .001). Adverse events consisted primarily of pharmacologically (noradrenergic) expected effects. Conclusions: Results of this open-label study support the long-term efficacy, safety, and tolerability of atomoxetine for the treatment of adult ADHD. (J. of Att. Dis. 2008; 12(3) 248-253)Keywords
This publication has 14 references indexed in Scilit:
- Atomoxetine in adults with ADHD: two randomized, placebo-controlled studiesBiological Psychiatry, 2003
- Once-Daily Atomoxetine Treatment for Children and Adolescents With Attention Deficit Hyperactivity Disorder: A Randomized, Placebo-Controlled StudyAmerican Journal of Psychiatry, 2002
- Atomoxetine in the Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: A Randomized, Placebo-Controlled, Dose-Response StudyPediatrics, 2001
- Attention-Deficit Hyperactivity DisorderScientific American, 1998
- Effectiveness and Tolerability of Tomoxetine in Adults With Attention Deficit Hyperactivity DisorderAmerican Journal of Psychiatry, 1998
- Diagnosis and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and AdolescentsJAMA, 1998
- Assessing Psychiatric Impairment in Primary Care with the Sheehan Disability ScaleThe International Journal of Psychiatry in Medicine, 1997
- A controlled study of methylphenidate in the treatment of attention deficit disorder, residual type, in adultsAmerican Journal of Psychiatry, 1985
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960
- THE ASSESSMENT OF ANXIETY STATES BY RATINGPsychology and Psychotherapy: Theory, Research and Practice, 1959